Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Condition(s):GlioblastomaLast Updated:March 8, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):GlioblastomaLast Updated:March 8, 2024Active, not recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:May 24, 2021Terminated
Condition(s):BeliefsLast Updated:March 12, 2024Completed
Condition(s):Thoracic; Pulmonary Injury; Heart InjuriesLast Updated:February 26, 2020Terminated
Condition(s):PancreaticoduodenectomyLast Updated:December 12, 2023Recruiting
Condition(s):Soft Tissue Sarcoma AdultLast Updated:April 27, 2023Recruiting
Condition(s):Colo-rectal Cancer; Polyps of ColonLast Updated:July 19, 2021Completed
Condition(s):Urothelial CarcinomaLast Updated:October 3, 2023Terminated
Condition(s):Pancreatic Neoplasm; Pancreatic Cyst; Pancreatic AbscessLast Updated:June 14, 2021Unknown status
Condition(s):Zenker Diverticulum; Diverticulum, Esophago-Pharyngeal; Diverticulum, Esophageal; Dysphagia; Gastrointestinal DiseaseLast Updated:August 14, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.